Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Clinical Data
Biotech
Despite ph. 3 miss, Alkeus sees path forward for eye disease med
Despite a phase 3 miss, Alkeus still sees a path forward for its oral eye disease asset.
Gabrielle Masson
Sep 17, 2024 10:58am
Lilly posts more positive data on once-weekly insulin prospect
Sep 11, 2024 2:05pm
Zealand Pharma’s GLP-1/GLP-2 agonist tied to 8.3% weight loss
Sep 10, 2024 10:45am
Lilly posts more positive data on its weekly insulin prospect
Sep 5, 2024 6:45am
Dyne shakes up C-suite after hazy DMD data drop
Sep 3, 2024 11:49am
Know Labs delivers positive data for needle-free glucose sensor
Jul 12, 2024 1:00pm